Cargando…
Quantifying the Value of Introducing an Oral Drug Delivery Option for Edaravone: A Review of Analyses Evaluating the Economic Impact of Oral versus Intravenous Formulations
BACKGROUND: Drug formulation and route of administration can have an impact on not only patients’ quality of life and disease outcomes but also costs of care. It is essential for decision makers to use appropriate economic modeling methods to guide drug coverage policies and to support patients’ dec...
Autores principales: | Ronquest, Naoko A, Paret, Kyle, Lucas, Aaron, Ciepielewska, Malgorzata, Hagan, Melissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342658/ https://www.ncbi.nlm.nih.gov/pubmed/35923520 http://dx.doi.org/10.2147/CEOR.S359025 |
Ejemplares similares
-
Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis
por: Brooks, Benjamin Rix, et al.
Publicado: (2022) -
Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects
por: Shimizu, Hidetoshi, et al.
Publicado: (2021) -
The evolution of ICER’s review process for new medical interventions and a critical review of economic evaluations (2018-2019): how stakeholders can collaborate with ICER to improve the quality of evidence in ICER’s reports
por: Ronquest, Naoko A, et al.
Publicado: (2021) -
Pharmacokinetics and Pharmacodynamics of an Oral Formulation of Apixaban in Horses After Oral and Intravenous Administration
por: Serpa, Priscila B. S., et al.
Publicado: (2018) -
Self-nanomicellizing solid dispersion of edaravone: part I – oral bioavailability improvement
por: Parikh, Ankit, et al.
Publicado: (2018)